1.Beta agonist regulation of sodium transport in fetal lung epithelium: roles of cell volume, cytosolic chloride and protein tyrosine kinase.
Yoshinori MARUNAKA ; Naomi NIISATO ; Yasushi ITO
Journal of Korean Medical Science 2000;15(Suppl):S42-S43
1) A beta agonist stimulated Na+ transport and decreased the intracellular Cl concentration ([Cl]c) associated with cell shrinkage via an increase in cytosolic cAMP level by activating adenylate cyclase in rat fetal distal lung epithelial (FDLE) cells. 2) Lowering [Cl-]c activated a 28-pS nonselective cation (NSC) channel by elongating the open time of the channel. 3) cAMP signals were converted to a protein tyrosine kinase (PTK)-mediated signal. 4) The PTK-mediated signal was involved in the cAMP-stimulated Na+ transport in rat FDLE cells.
Adrenergic beta-Agonists/pharmacology*
;
Animal
;
Biological Transport/physiology
;
Biological Transport/drug effects
;
Cell Size/physiology
;
Chlorides/metabolism*
;
Cyclic AMP/metabolism
;
Cytosol/metabolism
;
Enzyme Inhibitors/pharmacology
;
Female
;
Fetus/cytology
;
Forskolin/pharmacology
;
Nitrobenzoates/pharmacology
;
Pregnancy
;
Protein-Tyrosine Kinase/metabolism*
;
Rats
;
Rats, Wistar
;
Respiratory Mucosa/enzymology*
;
Respiratory Mucosa/embryology
;
Respiratory Mucosa/cytology
;
Sodium/metabolism*
;
Tyrphostins/pharmacology
2.Alternative expression and sequence of human elongation factor-1 delta during malignant transformation of human bronchial epithelial cells induced by cadmium chloride.
Yi-Xiong LEI ; Min WANG ; Lian WEI ; Xi LU ; Hua-Zhao LIN
Biomedical and Environmental Sciences 2010;23(2):151-157
OBJECTIVETo study the alternative expression and sequence of human elongation factor-1 delta (human EF-1 delta p31) during malignant transformation of human bronchial epithelial cells induced by cadmium chloride (CdC12) and its possible mechanism.
METHODSTotal RNA was isolated at different stages of transformed human bronchial epithelial cells (16HBE) induced by CdCl2 at a concentration of 5.0 microM. Special primers and probe for human EF-1 delta p31 were designed and expression of human EF-1 delta mRNA from different cell lines was detected with fluorescent quantitative PCR technique. EF-18 cDNA from different cell lines was purified and cloned into pMD 18-T vector followed by confirming and sequencing analysis.
RESULTSThe expressions of human EF-1 beta p31 at different stages of 16HBE cells transformed by CdCl2 was elevated (P < 0.01 or P < 0.05). Compared with their corresponding non-transformed cells, the overexpression level of EF-1 delta p31 was averagely increased 2.9 folds in Cd-pretransformed cells, 4.3 folds in Cd-transformed cells and 7.2 folds in Cd-tumorigenic cells. No change was found n the sequence of overexpressed EF-1beta p31 at different stages of 16HBE cells transformed by CdCl2.
CONCLUSIONOverexpression of human EF-1beta p31 is positively correlated with malignant transformation of 16HBE cells induced by CdC12, but is not correlated with DNA mutations.
Cadmium Chloride ; Cell Line ; Cell Transformation, Neoplastic ; chemically induced ; metabolism ; Epithelial Cells ; drug effects ; metabolism ; pathology ; Gene Expression Regulation, Neoplastic ; Humans ; Peptide Elongation Factor 1 ; genetics ; metabolism ; Respiratory Mucosa ; drug effects ; metabolism ; pathology ; Sequence Analysis, DNA
3.Ozone Exposure Suppresses Proliferative Response in Mice Skin.
Su Jung HAN ; Mi Kyung KWAK ; Dong Hoon HAN ; Shin Hee KIM ; An Soo JANG
The Korean Journal of Internal Medicine 2012;27(3):360-362
No abstract available.
Air Pollutants/*toxicity
;
Animals
;
Biological Markers/metabolism
;
Cell Proliferation/*drug effects
;
Female
;
Immunohistochemistry
;
Inhalation Exposure
;
Mice
;
Mice, Inbred BALB C
;
Nasal Mucosa/drug effects/pathology
;
Ozone/*toxicity
;
Proliferating Cell Nuclear Antigen/metabolism
;
Respiratory Mucosa/*drug effects/metabolism/pathology
;
Skin/*drug effects/metabolism/pathology
4.Suppression of CFTR-mediated Cl- Secretion of Airway Epithelium in Vitamin C-deficient Mice.
Yeryung KIM ; Hyemin KIM ; Hae Young YOO ; Jae Seung KANG ; Sung Joon KIM ; Jin Kyoung KIM ; Hyun Sung CHO
Journal of Korean Medical Science 2011;26(3):317-324
Hyperoxic ventilation induces detrimental effects on the respiratory system, and ambient oxygen may be harmful unless compensated by physiological anti-oxidants, such as vitamin C. Here we investigate the changes in electrolyte transport of airway epithelium in mice exposed to normobaric hyperoxia and in gulonolacton oxidase knock-out (gulo[-/-]) mice without vitamin C (Vit-C) supplementation. Short-circuit current (Isc) of tracheal epithelium was measured using Ussing chamber technique. After confirming amiloride-sensitive Na+ absorption (DeltaIsc,amil), cAMP-dependent Cl- secretion (DeltaIsc,forsk) was induced by forskolin. To evaluate Ca2+-dependent Cl- secretion, ATP was applied to the luminal side (DeltaIsc,ATP). In mice exposed to 98% PO2 for 36 hr, DeltaIsc,forsk decreased, DeltaIsc,amil and DeltaIsc,ATP was not affected. In gulo(-/-) mice, both DeltaIsc,forsk and DeltaIsc,ATP decreased from three weeks after Vit-C deprivation, while both were unchanged with Vit-C supplementation. At the fourth week, tissue resistance and all electrolyte transport activities were decreased. An immunofluorescence study showed that the expression of cystic fibrosis conductance regulator (CFTR) was decreased in gulo(-/-) mice, whereas the expression of KCNQ1 K+ channel was preserved. Taken together, the CFTR-mediated Cl- secretion of airway epithelium is susceptible to oxidative stress, which suggests that supplementation of the antioxidant might be beneficial for the maintenance of airway surface liquid.
Animals
;
Ascorbic Acid Deficiency/*metabolism
;
Biological Transport/drug effects
;
Chlorides/*metabolism
;
Cystic Fibrosis Transmembrane Conductance Regulator/antagonists & inhibitors/drug
;
Forskolin/pharmacology
;
Hyperbaric Oxygenation
;
Hyperoxia/*physiopathology
;
Ion Transport/drug effects
;
Mice
;
Mice, Inbred C57BL
;
Mice, Inbred ICR
;
Mice, Knockout/metabolism
;
Mice, Transgenic
;
Microscopy, Fluorescence
;
Oxidative Stress
;
Oxygen/adverse effects/pharmacology
;
Potassium Channels/metabolism
;
Respiratory Mucosa/drug effects/*metabolism/secretion
;
Sodium
;
Sugar Acids/metabolism
5.Role of extracellular signal-regulated kinase 1/2 in cigarette smoke-induced mucus hypersecretion in a rat model.
Jun XIAO ; Ke WANG ; Yu-Lin FENG ; Xue-Rong CHEN ; Dan XU ; Ming-Ke ZHANG
Chinese Medical Journal 2011;124(20):3327-3333
BACKGROUNDAirway mucus hypersecretion is an important pathophysiological feature of chronic obstructive pulmonary disease, which is closely associated with cigarette smoking. However, the signal transduction pathway from the cell surface to the nucleus through which cigarette smoke causes upregulation of mucin gene expression is not well known. This study was designed to investigate the role of extracellular signal-regulated Kinase 1/2 (ERK 1/2) in airway mucus hypersecretion induced by cigarette smoke in rats.
METHODSA rat model of airway mucus hypersecretion was induced by exposure to cigarette smoke for 4 weeks.Rats exposed to inhalation of cigarette smoke or normal saline were given an intraperitoneal injection of U0126, a specific MEK1 kinase inhibitor, at doses of 0.25 mg/kg, 0.5 mg/kg and 1 mg/kg for 14 days. Expression of MUC5AC mRNA and protein, ERK 1/2 and phosphorylated-ERK 1/2 (p-ERK 1/2) were detected by RT-PCR, immunohistochemistry and Western blotting.
RESULTSCigarette smoke significantly increased airway goblet cells metaplasia, induced the overexpression of MUC5AC mRNA and protein in bronchial epithelia, and increased the ratio of p-ERK 1/2 and ERK 1/2. U0126 significantly attentuated the expression of MUC5AC mRNA and protein induced by cigarette smoke (P < 0.05). Moreover, there was a significant positive correlation between the ratio of p-ERK1/2 to ERK1/2 and the expression of MUC5AC mRNA and protein (P < 0.05).
CONCLUSIONSInhibition of ERK 1/2 by U0126 decreased the ratio of p-ERK 1/2 to ERK 1/2 and expression of MUC5AC mRNA and protein. ERK 1/2 may play an essential role in cigarette smoke-induced mucus hypersecretion in vivo.
Animals ; Blotting, Western ; Bronchi ; cytology ; metabolism ; Goblet Cells ; drug effects ; metabolism ; Immunohistochemistry ; Lung ; drug effects ; metabolism ; Mitogen-Activated Protein Kinase 1 ; genetics ; metabolism ; Mitogen-Activated Protein Kinase 3 ; genetics ; metabolism ; Mucin 5AC ; genetics ; metabolism ; Phosphorylation ; drug effects ; Rats ; Respiratory Mucosa ; secretion ; Reverse Transcriptase Polymerase Chain Reaction ; Smoking ; adverse effects
6.Sulforaphane Induces Antioxidative and Antiproliferative Responses by Generating Reactive Oxygen Species in Human Bronchial Epithelial BEAS-2B Cells.
Journal of Korean Medical Science 2011;26(11):1474-1482
Sulforaphane (SFN) is a naturally occurring compound which is known to induce the phase II antioxidant genes via Nrf2 activation, although the underlying mechanism has not been fully elucidated. In this study, we investigated Nrf2 induction in response to SFN in human bronchial epithelial BEAS-2B cells and determined the signaling pathways involved in this process. SFN treatment reduced cell viability. Prior to cell death, intracellular reactive oxygen species (ROS) were generated at a high rate within a minute of commencing SFN treatment. Pretreatment with antioxidant N-acetylcysteine (NAC) blocked SFN-induced decrease in cell growth. Erk1/2 was activated within 30 min of SFN addition, whereas Akt phosphorylation did not significantly change until the first 8 hr after SFN treatment but then became substantially low until 48 hr. Inhibition of Erk1/2 phosphorylation attenuated SFN-induced loss of cell viability. Nrf2 protein levels in both nuclear and whole cell lysates were increased by SFN treatment, which was dependent on ROS production. Knockdown of Nrf2 with siRNA attenuated SFN-induced heme oxygenase-1 (HO-1) up-regulation. Induction of the Nrf2/HO-1 after SFN treatment was potently suppressed by pretreatment with NAC. Overall, our results indicate that SFN mediates antioxidative and antiproliferative responses by generating ROS in BEAS-2B cells.
Acetylcysteine/pharmacology
;
Anticarcinogenic Agents/pharmacology
;
Antioxidants/*pharmacology
;
Bronchi/cytology/*drug effects/metabolism
;
Cell Line
;
Cell Proliferation/*drug effects
;
Epithelial Cells/drug effects/metabolism
;
Extracellular Signal-Regulated MAP Kinases/metabolism
;
Free Radical Scavengers/pharmacology
;
Heme Oxygenase-1/biosynthesis
;
Humans
;
NF-E2-Related Factor 2/biosynthesis/genetics
;
Oxidative Stress/drug effects
;
Proto-Oncogene Proteins c-akt/metabolism
;
RNA Interference
;
RNA, Small Interfering
;
Reactive Oxygen Species/*metabolism
;
Respiratory Mucosa/cytology/*drug effects/metabolism
;
Signal Transduction/drug effects
;
Thiocyanates/*pharmacology
7.Effects of Scutellarin on MUC5AC Mucin Production Induced by Human Neutrophil Elastase or Interleukin 13 on Airway Epithelial Cells.
De Peng JIANG ; Juliy M PERELMAN ; Victor P KOLOSOV ; Xiang Dong ZHOU
Journal of Korean Medical Science 2011;26(6):778-784
Scutellarin is a flavonoid extracted from a traditional Chinese herb, Erigeron breviscapus. The present study investigated the effect of scutellarin on MUC5AC mucin production and the possible mechanism. Human bronchial epithelial 16 (HBE16) cells were pretreated with scutellarin for 60 min, and then exposed to human neutrophil elastase (HNE) or interleukin (IL)-13 for 12 hr. RT-PCR and ELISA were performed to measure the amount of MUC5AC mucin production. The results showed that scutellarin inhibited MUC5AC expression both in mRNA and protein level induced by HNE in a concentration-dependent manner. However, scutellarin failed to inhibit MUC5AC mucin production induced by IL-13. To investigate the intracellular mechanisms associated with the effect of scutellarin on MUC5AC mucin production, western blotting was carried out to examine the phosphorylation of protein kinase C (PKC), signal transducer and activator of transcription 6 (STAT6) and extracellular signal-regulated kinase 1/2 (ERK1/2). The phosphorylation of PKC and ERK1/2 was attenuated after treatment with scutellarin, whereas STAT6 was not significantly affected. Therefore, it is suggested that scutellarin down-regulates MUC5AC mucin production on HBE16 cells via ERK-dependent and PKC-dependent pathways.
Apigenin/chemistry/*pharmacology
;
Cells, Cultured
;
Dose-Response Relationship, Drug
;
Down-Regulation
;
Epithelial Cells/*drug effects/metabolism
;
Erigeron/chemistry
;
Glucuronic Acids/chemistry/*pharmacology
;
Humans
;
Interleukin-13/*pharmacology
;
Leukocyte Elastase/*pharmacology
;
Mitogen-Activated Protein Kinase 1/metabolism
;
Mitogen-Activated Protein Kinase 3/metabolism
;
Mucin 5AC/genetics/*metabolism
;
Phosphorylation
;
Protein Kinase C/metabolism
;
Respiratory Mucosa/drug effects/*metabolism
;
STAT6 Transcription Factor/metabolism
;
Signal Transduction
8.Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation.
Gyu Young HUR ; Sung Yong LEE ; Seung Hyeun LEE ; Se Joong KIM ; Kyoung Ju LEE ; Jin Yong JUNG ; Eun Joo LEE ; Eun Hae KANG ; Ki Hwan JUNG ; Sang Yeub LEE ; Je Hyeong KIM ; Chol SHIN ; Jae Jeong SHIM ; Kwang Ho IN ; Kyung Ho KANG ; Se Hwa YOO
Experimental & Molecular Medicine 2007;39(3):367-375
The EGFR plays an essential role in goblet cell hyperplasia and mucus hypersecretion. EGFR has an intrinsic tyrosine kinase activity that, when activated, induces the production of MUC5AC through the signaling kinase cascade in the airway epithelium. We have investigated the effects of an EGFR tyrosine kinase inhibitor, gefitinib, on ovalbumin (OVA)-induced, allergic inflammation in airway epithelia of mice. OVA-sensitized mice were pretreated with gefitinib at two different doses (12.5 and 50 mg/kg) and then challenged with OVA. The OVA challenge increased the total cell count and eosinophil count in bronchoalveolar lavage fluid (BALF), as well as the concentrations of T-helper2 (Th2) cytokines, such as IL-4 and IL-13, overall eosinophil recruitment in the lung tissue and airway hyperresponsiveness (AHR). Pretreatment with gefitinib reduced the inflammatory cell counts and released cytokine concentrations (IL-4 and IL-13) in BALF, as well as eosinophil recruitment in the lungs and AHR, in a dose-dependent manner. This was associated with decreased EGFR and Akt phosphorylation. We showed that gefitnib inhibits EGFR and phosphoinositol 3'-kinase (PI3K)/Akt activation which were activated in OVA sensitized mice. These findings suggest that inhibitors of the EGFR cascade may have a role in the treatment of asthma.
Animals
;
Antineoplastic Agents/*therapeutic use
;
Bronchoalveolar Lavage Fluid/cytology
;
Cytokines/biosynthesis
;
Enzyme Activation
;
Eosinophils/cytology
;
Goblet Cells/pathology
;
Inflammation/drug therapy/metabolism
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Ovalbumin
;
Phosphorylation
;
Proto-Oncogene Proteins c-akt/metabolism
;
Quinazolines/*therapeutic use
;
Receptor, Epidermal Growth Factor/*antagonists & inhibitors/metabolism
;
Respiratory Hypersensitivity/*drug therapy/etiology/metabolism
;
Respiratory Mucosa/drug effects/pathology
9.Unexpected effects of pathogens on epithelial Na+ channels.
Karl KUNZELMANN ; Alex BEESLEY ; Nicholas KING ; Guna KARUPIAH ; John YOUNG ; David COOK
Journal of Korean Medical Science 2000;15(Suppl):S59-S60
No abstract available.
Animal
;
Biological Transport/physiology
;
Biological Transport/drug effects
;
Cholera/metabolism
;
Diglycerides/pharmacology
;
Epithelial Cells*/virology
;
Epithelial Cells*/microbiology
;
Epithelial Cells*/metabolism
;
Escherichia coli
;
Escherichia coli Infections/metabolism
;
Estrenes/pharmacology
;
In Vitro
;
Indoles/pharmacology
;
Influenza/metabolism
;
Intestinal Mucosa/cytology
;
Maleimides/pharmacology
;
Mice
;
Phosphodiesterase Inhibitors/pharmacology
;
Pyrrolidinones/pharmacology
;
Respiratory Mucosa/cytology
;
Sodium Channels/metabolism*
;
Staurosporine/pharmacology
;
Vibrio cholerae
10.Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats.
Hong-mei QIAO ; Ji-rong LU ; Huan-ji CHENG ; Li LIU ; Qing-shan MA ; Wen-yong FU ; Fang-xing ZHAO
Chinese Journal of Pediatrics 2005;43(8):591-594
OBJECTIVETo investigate the role of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in the pathogenesis of bronchial asthma and assess the effect of steroid treatment on MMP-9 and TIMP-1 levels. Matrix metalloproteinases are a family of zinc and calcium-dependent endopeptidases. Many MMPs such as MMP-1, MMP-2, MMP-3 are associated with asthma, in which MMP-9 is the key factor in asthma. Tissue inhibitor-1 of metalloproteinases is a specific inhibitor of MMP-9; the MMP-9 and TIMP-1 imbalance could lead to airway inflammation and remodeling in lung disease such as asthma.
METHODSForty Wistar rats were divided into 4 groups randomly: control, asthma model 7 days (7-day group), asthma model 21 days (21-day group) and steroid treatment groups. Asthma model of rats were established by ovalbumin (OVA) sensitization and challenge with mist inhalation. The expression of MMP-9 and TIMP-1 in lung tissues was detected by immunocytochemistry, RT-PCR and Western blotting.
RESULTS(1) By observing the changes of action, tracing respiratory curves, detecting level of serum IgE level and observing the lung tissues sections, the authors demonstrated that the rat asthmatic models were successfully established. (2) The lung tissue sections of the asthma groups stained with hematoxiline and eosin (HE) showed many inflammatory cell infiltrations around the bronchioli and accompanying arterioles, hyperplasia of caliciform cells, broken bronchial mucous membrane and thickening of submucosal layer. The hyperplasia of airway smooth muscle and basement membrane were more significant in asthma model 21-day group than that in 7-day group. These changes were improved after treatment. (3) The expression of MMP-9 in rat's lung tissues: the expression was 2.71 +/- 0.37 in 7-day group, 1.76 +/- 0.27 in 21-day group, 0.88 +/- 0.18 in the treatment group and 0.52 +/- 0.10 in the control group (F = 151.52, P < 0.01). The expression of TIMP-1 in rat's lung tissues was 1.13 +/- 0.19 in the 7-day group, 1.55 +/- 0.24 in 21-day group, 0.77 +/- 0.15 in the treatment group and 0.47 +/- 0.08 in the control group (F = 69.46, P < 0.01). (4) The results of immunocytochemistry and protein expression were consistent with those of RT-PCR.
CONCLUSIONThe protein and mRNA expression level of MMP-9 and TIMP-1 was high in asthmatic rat's lung tissues. Down-regulation of the expression of MMP-9 and TIMP-1 by steroids may be one of the mechanisms by which airway inflammation and remodeling are inhibited in asthma.
Administration, Inhalation ; Animals ; Asthma ; drug therapy ; metabolism ; Blotting, Western ; Bronchi ; metabolism ; pathology ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Gene Expression Regulation, Enzymologic ; Glucocorticoids ; administration & dosage ; therapeutic use ; Immunohistochemistry ; Inflammation ; drug therapy ; metabolism ; pathology ; Lung ; drug effects ; metabolism ; pathology ; Male ; Matrix Metalloproteinase 9 ; genetics ; metabolism ; Rats ; Rats, Wistar ; Respiratory Mucosa ; drug effects ; metabolism ; pathology ; Reverse Transcriptase Polymerase Chain Reaction ; Tissue Inhibitor of Metalloproteinase-1 ; genetics ; metabolism